Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationCyclophosphamidePeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeMultiple MyelomaMelphalanTransplantation ConditioningTransplantation, HomologousSalvage TherapyLymphoma, Non-HodgkinRemission InductionStem CellsDisease-Free SurvivalEtoposideAntineoplastic AgentsHodgkin DiseaseVincristineRecurrenceMyeloablative AgonistsCytarabineCarmustineBone Marrow TransplantationSurvival RateThiotepaHematopoietic Stem Cell MobilizationGraft vs Host DiseaseDoxorubicinSurvival AnalysisBone Marrow PurgingHematologic NeoplasmsWhole-Body IrradiationAntineoplastic Agents, AlkylatingBusulfanLymphoma, Mantle-CellRetrospective StudiesAmyloidosisDexamethasoneHematopoietic Stem CellsAntibodies, Monoclonal, Murine-DerivedPrognosisBoronic AcidsPyrazinesGraft SurvivalFollow-Up StudiesPrednisoneLymphoma, FollicularChemotherapy, AdjuvantIfosfamideAntigens, CD34Time FactorsGranulocyte Colony-Stimulating FactorLymphoma, T-Cell, PeripheralThalidomideAutograftsLiver TransplantationInduction ChemotherapyLeukapheresisLymphomaMesenchymal Stem Cell TransplantationDose-Response Relationship, DrugPodophyllotoxinLymphoma, Large B-Cell, DiffuseTransplantation ChimeraNeoplasm, ResidualMaintenance ChemotherapyImmunosuppressive AgentsDrug Administration ScheduleLeukemia, Myeloid, AcuteTissue DonorsCord Blood Stem Cell TransplantationMitoxantroneCisplatinLymphoma, B-CellCell TransplantationMyelodysplastic SyndromesKidney TransplantationCarboplatinProspective StudiesIdarubicinEnteropathy-Associated T-Cell LymphomaNeoplasms, Second PrimaryEmbryonic Stem CellsLeukemia, Plasma CellInfusions, SpinalAntibodies, MonoclonalBlood Component RemovalNeoplasm Recurrence, LocalAdult Stem CellsNeutropeniaFeasibility StudiesHistocompatibility TestingBreast NeoplasmsVidarabineLeukemia, MyeloidBone MarrowFatal Outcome